Labelling and Clinical Performance of Human Leukocytes Labelled with <sup>99m</sup>Tc-HMPAO Using Leukokit® with Gelofusine versus Leukokit® with HES as Sedimentation Agent

<div>Graphic representation of the spontaneous <i>in vitro</i> release of <sup>99m</sup>Tc-HMPAO from labelled WBCs at different time points (data are mean of 6 subjects ± SD).</div>

Contrast Media & Molecular Imaging

fig7

Figure 7

Figure 7: Labelling and Clinical Performance of Human Leukocytes Labelled with <sup>99m</sup>Tc-HMPAO Using Leukokit® with Gelofusine versus Leukokit® with HES as Sedimentation Agent 

Figure 7 | Labelling and Clinical Performance of Human Leukocytes Labelled with 99mTc-HMPAO Using Leukokit® with Gelofusine versus Leukokit® with HES as Sedimentation Agent 